Prediction of Early Death in Adults with Relapsed or Refractory Acute Myeloid Leukemia

Documenti analoghi

• Diagnostic Utility of Bronchoscopy in Adults with Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
  di: Buckley, Sarah A., et al.
  Pubblicazione: (2019)
• Cyclosporine Modulation of Multidrug Resistance in Combination with Pravastatin, Mitoxantrone, and Etoposide for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study
  di: Chen, Tara L., et al.
  Pubblicazione: (2013)
• Prediction of Adverse Events during Intensive Induction Chemotherapy for Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes
  di: Buckley, Sarah A., et al.
  Pubblicazione: (2014)
• Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG
  di: Walter, Roland B., et al.
  Pubblicazione: (2015)
• Randomized Phase 1 Study of Sequential (“Primed”) vs. Concurrent Decitabine in Combination with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm
  di: Palmieri, Raffaele, et al.
  Pubblicazione: (2020)